Fenwick & West represented Morphic Holdings, Inc. in the transaction, and Kirkland & Ellis represented Eli Lilly and Company. Eli Lilly and Company (NYSE: LLY) announced...
You must be a Standard 1 Year member to access this content.
Fenwick & West is representing Databricks in the transaction. Databricks, the Data and AI company, announced its pending acquisition of Tabular, a cloud-native data platform from...
You must be a Standard 1 Year member to access this content.
Fenwick & West is advising Escient Pharmaceuticals on the transaction, and Covington & Burling is advising Incyte. Incyte (Nasdaq:INCY) announced the acquisition of Escient Pharmaceuticals (“Escient”). Incyte...
You must be a Standard 1 Year member to access this content.
Skadden advised Vertex Pharmaceuticals Incorporated, while Fenwick & West advised Alpine in the transaction. Vertex Pharmaceuticals Incorporated and Alpine Immune Sciences, Inc. have entered into a definitive...
You must be a Standard 1 Year member to access this content.
Willkie Farr & Gallagher is advising Take-Two Interactive Software, Inc. on the transaction, and Fenwick & West is advising Embracer Group. Embracer Group announced has entered...
You must be a Standard 1 Year member to access this content.
Fenwick & West represented Satelles in the transaction. Iridium Communications Inc. (NASDAQ: IRDM) announced it has entered into a definitive agreement to acquire Satelles, Inc., the leader...
You must be a Standard 1 Year member to access this content.
Fenwick & West is representing Cisco Systems, Inc. on the transaction. Cisco Systems, Inc. (NASDAQ: CSCO) announced its pending acquisition of Isovalent, a developer of an open-source...
You must be a Standard 1 Year member to access this content.
Snell & Wilmer represented Insight Enterprises in the transaction, and Fenwick & West represented SADA. Insight Enterprises (NASDAQ:NSIT) announced it has completed the acquisition of SADA, a leading cloud...
You must be a Standard 1 Year member to access this content.
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo advised Standard BioTools Inc. on the transaction, and Fenwick & West advised SomaLogic, Inc. Standard BioTools Inc. (Nasdaq: LAB) and SomaLogic (Nasdaq:...
You must be a Standard 1 Year member to access this content.
Fenwick & West LLP represented DICE Therapeutics, Inc. in the transaction, while Kirkland & Ellis represented Eli Lilly and Company. Eli Lilly and Company (NYSE: LLY)...
You must be a Standard 1 Year member to access this content.
Fenwick advised NS1 on the deal. NS1, a provider of network automation SaaS solutions that are designed to enable businesses to deliver content, services and applications...
You must be a Standard 1 Year member to access this content.
Skadden and Katten Muchin Rosenman acted as legal advisor to SMS Assist in the transaction, while Fenwick & West acted as legal counsel to Lessen. Lessen...
You must be a Standard 1 Year member to access this content.
